Evaluate IMG-007 in Healthy Participants

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2022
This first in human (FIH) study will evaluate the safety, tolerability, pharmacokinetics (PK)), and immunogenicity of a single ascending dose of IMG-007 in healthy participants.
Epistemonikos ID: 6c99288cf9d921c33ccd78b26aafc9ccffe36e4a
First added on: Oct 02, 2023